Cas:5346-58-7 1,3-dimethylpyrazolo[3,4-d]pyrimidin-4-amine manufacturer & supplier

Chemical Name:1,3-dimethylpyrazolo[3,4-d]pyrimidin-4-amine

CAS.NO:5346-58-7

Synonyms:1,3-dimethyl-1h-pyrazolo[3,4-d]pyrimidin-4-amine;4-amino-1,3-dimethylpyrazolo<3,4-d>pyrimidine;1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine;4-amino-1,3-dimethyl-1H-pyrazolo<3,4-d>pyrimidine;1,3-Dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamin;4-AMINO-1,4-D]PYRIMIDINE

Molecular Formula:C₇H₉N₅

Molecular Weight:163.18000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:362.9ºC at 760 mmHg

Density:1.5g/cm3

Index of Refraction:1.757

PSA:69.62000

Exact Mass:163.08600

LogP:0.83510

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,3-dimethyl-1h-pyrazolo[3,4-d]pyrimidin-4-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-AMINO-1,4-D]PYRIMIDINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,pyrimidine Use and application,4-AMINO-1,4-D]PYRIMIDINE technical grade,usp/ep/jp grade.

Related News: But one clear concern among the CDC’s expert group this time around was the rapidly spreading Delta variant, first found in India. That mutated strain now accounts for over 80% of new U.S. infections that are sequenced, CDC data shows. 1-methyl-1-(4-nitrophenyl)-2,2-diphenyl-2,8-dihydro-1H-azeto[2,1-b]quinazoline manufacturers The CDC’s Advisory Committee on Immunization Practices (ACIP) decision on Thursday came after an hours-long discussion over a handful of Guillain-Barré syndrome (GBS) cases reported after J&J’s jab. The independent group of experts were also tasked with reviewing the need for booster shots, specifically for people with compromised immune systems. 9-hexyl-10-bromo-2,3,6,7-tetramethylanthracene suppliers So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off. 7-(((benzyloxy)carbonyl)amino)-3-((S)-1-(N-(tert-butoxycarbonyl)-N-methyl-D-phenylalanyl)pyrrolidine-2-carboxamido)-2-oxohept-5-ynoic acid vendor & factory Here’s how Biogen did during the three months ended June 30 compared with what Wall Street expected, according to average estimates compiled by Refinitiv.,The CDC’s Advisory Committee on Immunization Practices (ACIP) decision on Thursday came after an hours-long discussion over a handful of Guillain-Barré syndrome (GBS) cases reported after J&J’s jab. The independent group of experts were also tasked with reviewing the need for booster shots, specifically for people with compromised immune systems.